Pomalidomide, Cyclophosphamide, And Dexamethasone For The Treatment Of Relapsed/ Refractory Multiple Myeloma: Real-World Analysis Of The Pethema-Gem Experience Paula Rodriguez-Otero , Maialen Sirvent , Ana Pilar González-Rodríguez , Esperanza Lavilla , Alfonso García de Coca , José María Arguiñano , Josep M Martí , Valentin Cabañas , Cristina Motlló , Erik de Cabo , Cristina Encinas , Ilda Murillo , Jose Ángel Hernández-Rivas , Ernesto Pérez-Persona , Felipe Casado , Antonia Sampol , Ricarda García , María Jesús Blanchard , Magdalena Anguita , Ana Paz Lafuente , Belén Iñigo , Aurelio López , Paz Ribas , Mario Arnao , Roberto Maldonado , Joan Bladé , María Victoria Mateos , Juan José Lahuerta , Jesús F San Miguel CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2021）
关键词
Lenalidomide-refractoriness, Pomalidomide, Real-world study, Refractory multiple myeloma, Triplet therapy
AI 理解论文
溯源树
样例
